Truist lowered the firm’s price target on BKV Corp. (BKV) to $30 from $31 and keeps a Buy rating on the shares as part of a broader research note reviewing Q4 results in Energy. The firm is adjusting its model to reflect the company’s performance and guidance, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BKV:
- BKV Corp. price target lowered to $25 from $27 at KeyBanc
- BKV Corporation’s Balanced Earnings Call Highlights Achievements and Challenges
- BKV Corporation: Strategic Initiatives and Financial Performance Drive Buy Rating
- BKV Corporation Reports 2024 Earnings and 2025 Outlook
- BKV Corp: Temple Plants reported capacity factor 37.5% in Q4